S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
Closely fought German election ushers in post-Merkel era
What's the price of Biden’s plan? Democrats drive for zero
German vote nearly even for Merkel's bloc, Social Democrats
Pelosi vows to pass infrastructure, eyes smaller social bill
Start a Side Hustle by Selling on Amazon
Asian shares up, Shanghai slips as virus fears cloud outlook
Pelosi vows to pass $1T bill, move ahead on larger measure
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
Closely fought German election ushers in post-Merkel era
What's the price of Biden’s plan? Democrats drive for zero
German vote nearly even for Merkel's bloc, Social Democrats
Pelosi vows to pass infrastructure, eyes smaller social bill
Start a Side Hustle by Selling on Amazon
Asian shares up, Shanghai slips as virus fears cloud outlook
Pelosi vows to pass $1T bill, move ahead on larger measure
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
Closely fought German election ushers in post-Merkel era
What's the price of Biden’s plan? Democrats drive for zero
German vote nearly even for Merkel's bloc, Social Democrats
Pelosi vows to pass infrastructure, eyes smaller social bill
Start a Side Hustle by Selling on Amazon
Asian shares up, Shanghai slips as virus fears cloud outlook
Pelosi vows to pass $1T bill, move ahead on larger measure
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
Closely fought German election ushers in post-Merkel era
What's the price of Biden’s plan? Democrats drive for zero
German vote nearly even for Merkel's bloc, Social Democrats
Pelosi vows to pass infrastructure, eyes smaller social bill
Start a Side Hustle by Selling on Amazon
Asian shares up, Shanghai slips as virus fears cloud outlook
Pelosi vows to pass $1T bill, move ahead on larger measure
NASDAQ:CNSP

CNS Pharmaceuticals Earnings Date, Estimates, & History

$1.49
-0.02 (-1.32 %)
(As of 09/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.47
▼
$1.52
50-Day Range
$1.40
▼
$1.84
52-Week Range
$1.39
▼
$4.46
Volume66,200 shs
Average Volume801,678 shs
Market Capitalization$40.92 million
P/E RatioN/A
Dividend YieldN/A
Beta2.34

Earnings Summary

Upcoming
Earnings Date
Nov. 11
Estimated

Actual EPS
(Aug. 12)
-$0.15
Beat By $0.01

Consensus EPS
(Aug. 12)
-$0.16

Last Year's Q3 EPS
(8/10/2020)
-$0.15

Earnings Per ShareRevenue

CNS Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CNS Pharmaceuticals Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CNS Pharmaceuticals (NASDAQ:CNSP) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.84 EPS
Next Year EPS Consensus Estimate: $-0.68 EPS

CNSP Earnings Information

CNS Pharmaceuticals last posted its earnings data on August 12th, 2021. The reported ($0.15) EPS for the quarter, topping analysts' consensus estimates of ($0.16) by $0.01. CNS Pharmaceuticals has generated ($0.57) earnings per share over the last year (($0.60) diluted earnings per share). Earnings for CNS Pharmaceuticals are expected to grow in the coming year, from ($0.84) to ($0.68) per share. CNS Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 11th, 2021 based off prior year's report dates.

CNS Pharmaceuticals (NASDAQ:CNSP) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
11/11/2021
(Estimated)		        
8/12/2021($0.16)($0.15)+$0.01($0.15)
5/14/2021Q1($0.12)($0.15)($0.03)($0.15)
2/12/2021Q4 2020($0.09)($0.18)($0.09)($0.18)
11/12/2020Q3 2020($0.12)($0.12)($0.12)
8/10/2020Q2 2020($0.15)($0.15)($0.15)
5/15/2020Q1 2020($0.12)($0.12)($0.12)
3/12/202012/31/2019($0.03)($0.17)($0.14)($0.17)  
(Earnings results data provided by Zacks Investment Research)
speech bubbles
speech bubbles











CNS Pharmaceuticals (NASDAQ:CNSP) Earnings Frequently Asked Questions

When is CNS Pharmaceuticals's earnings date?

CNS Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 11th, 2021 based off last year's report dates. Learn more on CNSP's earnings history

Did CNS Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, CNS Pharmaceuticals (NASDAQ:CNSP) reported ($0.15) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.16) by $0.01. Learn more on CNSP's earnings details

How much profit does CNS Pharmaceuticals generate each year?

CNS Pharmaceuticals (NASDAQ:CNSP) has a recorded net income of -$9.46 million. CNSP has generated -$0.57 earnings per share over the last four quarters.

What is CNS Pharmaceuticals's EPS forecast for next year?

CNS Pharmaceuticals's earnings are expected to grow from ($0.84) per share to ($0.68) per share in the next year.

This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.